Company Details
  • Taizhou Volsen Chemical Co., Ltd.

  •  [Zhejiang,China]
  • Business Type:Manufacturer
  • Main Mark: Americas , Asia , East Europe , Europe , North Europe , Other Markets , West Europe , Worldwide
  • Exporter:91% - 100%
  • Certs:GS, CE, ISO9001, ISO14000
  • Description:1195768-06-9,CAS 1195768-06-9,High Quality Dabrafenib Mesylate
Taizhou Volsen Chemical Co., Ltd. 1195768-06-9,CAS 1195768-06-9,High Quality Dabrafenib Mesylate
Home > Products > Contract Manufacturing > 1195768-06-9,High Purity Dabrafenib Mesylate

1195768-06-9,High Purity Dabrafenib Mesylate

Share to:  
    Unit Price: 1~1 USD
    Payment Type: T/T
    Incoterm: FOB
    Min. Order: 1 Kilogram
    Delivery Time: 15 Days

Basic Info

Model No.: 1195768-06-9

Additional Info

Packaging: AS REQUIRED

Productivity: KGS


Place of Origin: CHINA


Certificate: ISO

Product Description

In our product range, we offer a superior quality range of Dabrafenib Mesylate CAS 1195768-06-9. Dabrafenib Mesylate CAS NO 1195768-09-6, also known as GSK-2118436B that is a selective BRAF V600E inhibitor and is widely used to anticancer. It is processed under monitoring of quality controllers in order to offer an international quality standard product range. High purity and stability are its salient features.

l Thera. Category:Anti- cancer

l Cas No.: 1195768-06-9

l Synonym:Dabrafenib Mesylate(GSK-2118436B);Dabrafenib Mesylate;GSK 2118436 Mesylate;GSK 2118436B;GSK2118436 Mesylate;GSK-2118436 Mesylate;Dabrafenib Mesylate (API);GSK 2118436 methanesulfonate salt

l Molecular Formula:C24H24F3N5O5S3


l Molecular Weight:615.6680696

l Assay: ≥97.%

l Packing:Export worthy packing

l Material Safety Data Sheet:Available on request

l Usage: Dabrafenib, also known as GSK2118436, is an orally bioavailable inhibitor of B-raf (BRAF) protein with potential antineoplastic activity. Dabrafenib selectively binds to and inhibits the activity of B-raf, which may inhibit the proliferation of tumor cells which contain a mutated BRAF gene. B-raf belongs to the the raf/mil family of serine/threonine protein kinases and plays a role in regulating the MAP kinase/ERKs signaling pathway, which may be constitutively activated due to BRAF gene mutations. On May 29, 2013, FDA approved this drug.

Related Intermediates :

1. CAS 630-22-8,2,2,2-Trimethylthioacetamide

Looking for ideal 1195768-06-9 Manufacturer & supplier ? We have a wide selection at great prices to help you get creative. All the CAS 1195768-06-9 are quality guaranteed. We are China Origin Factory of High Quality Dabrafenib Mesylate. If you have any question, please feel free to contact us.

Product Categories : Contract Manufacturing

Product Images
  • 1195768-06-9,High Purity Dabrafenib Mesylate
Email to this supplier
  • *Subject:
  • *Messages:
    Your message must be between 20-8000 characters
Copyright © 2019 Taizhou Volsen Chemical Co., Ltd. All rights reserved.
Communicate with Supplier?Supplier
Amy Cheng Ms. Amy Cheng
What can I do for you?